Literature DB >> 33139390

Incidental detection, imaging modalities and temporal trends of differentiated thyroid cancer in Ontario: a population-based retrospective cohort study.

Todd A Norwood1, Emmalin Buajitti2, Lorraine L Lipscombe2, Thérèse A Stukel2, Laura C Rosella2.   

Abstract

BACKGROUND: Incidence rates of thyroid cancer in Ontario have increased more rapidly than those of any other cancer, whereas mortality rates have remained relatively stable. We evaluated the extent to which incidental detection of differentiated thyroid cancer during unrelated prediagnostic imaging procedures contributed to Ontario's incidence rates.
METHODS: We conducted a retrospective cohort study involving Ontarians who received a diagnosis of differentiated thyroid cancer from 1998 to 2017 using linked health care administrative databases. We classified cases as incidentally detected if a nonthyroid diagnostic imaging test (e.g., computed tomography [CT]) preceded an index event (e.g., prediagnostic fine-needle aspiration biopsy); all other cases were nonincidentally detected cases. We used Joinpoint and negative binomial regressions to characterize sex-specific rates of differentiated thyroid cancer by incidentally detected status and to quantify potential age, diagnosis period and birth cohort effects.
RESULTS: The study included 36 531 patients with differentiated thyroid cancer, of which 78.7% were female. Incidentally detected cases increased from 7.0% to 11.0% of female patients and from 13.5% to 18.2% of male patients over the study period. Age-standardized incidence rates increased more rapidly for incidentally detected cases (4.2-fold for female and 3.7-fold for male patients) than for nonincidentally detected cases (2.6-fold for female and 3.0-fold for male patients; p < 0.001). Diagnosis period was the primary factor associated with increased incidence rates of differentiated thyroid cancer, adjusting for other factors. Within each period, incidentally detected rates increased faster than nonincidentally detected rates, adjusting for age. Our results showed that CT was the most common imaging procedure preceding incidentally detected diagnoses.
INTERPRETATION: Incidentally detected cases represent a large and increasing component of the observed increases in differentiated thyroid cancer in Ontario over the past 20 years, and CT scans are primarily associated with these cases despite the modality having similar, increasing rates of use compared with magnetic resonance imaging (1993-2004). Recent increases in rates of differentiated thyroid cancer among males and incidentally detected cases among females in Ontario appear to be unrelated to birth cohort effects. Copyright 2020, Joule Inc. or its licensors.

Entities:  

Mesh:

Year:  2020        PMID: 33139390      PMCID: PMC7608946          DOI: 10.9778/cmajo.20200095

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  35 in total

1.  Thyroid Biopsy Specialists: A Quality Initiative to Reduce Wait Times and Improve Adequacy Rates.

Authors:  Sangeet Ghai; Stefanie Y Lee; Patrice M Bret; Ravi J Menezes; Scott L Boerner; Yongheng Jia; Kulsoom A Maan; Rudolf Boci; Wasim Javed; Mostafa Atri
Journal:  Radiology       Date:  2015-04-20       Impact factor: 11.105

Review 2.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

3.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.

Authors:  Hyeyeun Lim; Susan S Devesa; Julie A Sosa; David Check; Cari M Kitahara
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

Review 4.  The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer.

Authors:  Douglas Van Nostrand
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

5.  Utilization patterns of diagnostic imaging across the late life course: a population-based study in Ontario, Canada.

Authors:  Li Wang; Jason X Nie; C Shawn Tracy; Rahim Moineddin; Ross E G Upshur
Journal:  Int J Technol Assess Health Care       Date:  2008       Impact factor: 2.188

6.  Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease.

Authors:  William D T Kent; Stephen F Hall; Phillip A Isotalo; Robyn L Houlden; Ralph L George; Patti A Groome
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

7.  Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer.

Authors:  James X Wu; Stephanie Young; Kevin Ro; Ning Li; Angela M Leung; Harvey K Chiu; Avital Harari; Michael W Yeh
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

8.  Thyroid cancer incidence and socioeconomic indicators of health care access.

Authors:  Brian L Sprague; Shaneda Warren Andersen; Amy Trentham-Dietz
Journal:  Cancer Causes Control       Date:  2008-02-01       Impact factor: 2.506

9.  Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Michael J Barry; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Silverstein; Melissa A Simon; Albert L Siu; Chien-Wen Tseng
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272

10.  Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects.

Authors:  S Liu; R Semenciw; A M Ugnat; Y Mao
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.